Are Onglyza and Kombiglyze XR Related to Heart Failure and Cardiac Arrest?

Stethoscope on prescription pad.

Onglyza (saxaglyptin) and Kombiglyze XR (saxaglyptin/metformin HCl) are prescription medications used to treat Type 2 diabetes. In April 2016, the FDA added new safety warnings to the two medications, indicating that saxaglyptin is associated with an increased risk of heart failure, as well as a higher risk of death from all causes.

At least 84 lawsuits are now pending against the pharmaceutical companies that make Onglyza and Kombiglyze XR, AstraZeneca and Bristol-Myers Squibb. The lawsuits allege that the manufacturers of Onglyza and Kombiglyze XR concealed information showing that the drugs caused an increased risk of heart failure.

If you took Onglyza or Komblglyze and later experienced cardiac arrest or were diagnosed with congestive heart failure, you may be entitled to compensation. If a loved one died from cardiac arrest or congestive heart failure after taking one of these drugs, then there may be a claim that person’s survivors can make for wrongful death.

If you believe that you or a loved one suffered a heart problem after taking Onglyza or Kombiglyze XR, the attorneys at Strauss Troy are currently investigating potential claims from consumers. You should be aware that there is a time limit to file these lawsuits so it’s important that you act quickly if you believe that you or a loved one may have a claim. If you would like us to evaluate your case, please contact Ron Parry at 513-621-2120 or